Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.

Vincent I, Jicha G, Rosado M, Dickson DW.

J Neurosci. 1997 May 15;17(10):3588-98.

2.

Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease.

Vincent I, Bu B, Hudson K, Husseman J, Nochlin D, Jin L.

Neuroscience. 2001;105(3):639-50.

PMID:
11516829
3.

Mitotic epitopes are incorporated into age-dependent neurofibrillary tangles in Niemann-Pick disease type C.

Zhang M, Wang X, Jiang F, Wang W, Vincent I, Bu B.

Brain Pathol. 2010 Mar;20(2):367-77. doi: 10.1111/j.1750-3639.2009.00286.x. Epub 2009 May 20.

PMID:
19476463
4.

Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.

Dranovsky A, Vincent I, Gregori L, Schwarzman A, Colflesh D, Enghild J, Strittmatter W, Davies P, Goldgaber D.

Neurobiol Aging. 2001 Jul-Aug;22(4):517-28.

PMID:
11445251
5.

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.

Pei JJ, Grundke-Iqbal I, Iqbal K, Bogdanovic N, Winblad B, Cowburn RF.

Brain Res. 1998 Jun 29;797(2):267-77.

PMID:
9666145
6.

Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.

Kondratick CM, Vandré DD.

J Neurochem. 1996 Dec;67(6):2405-16.

PMID:
8931473
7.

Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.

Zhu X, McShea A, Harris PL, Raina AK, Castellani RJ, Funk JO, Shah S, Atwood C, Bowen R, Bowser R, Morelli L, Perry G, Smith MA.

J Neurosci Res. 2004 Mar 1;75(5):698-703.

PMID:
14991845
8.
9.
10.

Mitotic mechanisms in Alzheimer's disease?

Vincent I, Rosado M, Davies P.

J Cell Biol. 1996 Feb;132(3):413-25.

11.

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Augustinack JC, Schneider A, Mandelkow EM, Hyman BT.

Acta Neuropathol. 2002 Jan;103(1):26-35.

PMID:
11837744
12.
13.

G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW.

J Biol Chem. 1993 Apr 15;268(11):8298-308.

14.

The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.

Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.

Acta Neuropathol. 2002 Feb;103(2):91-9. Epub 2001 Nov 29.

PMID:
11810173
15.

Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.

Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, Carmona M, Blanco R, Puig B.

Brain Pathol. 2003 Jan;13(1):62-78.

PMID:
12580546
16.

Reconstitution of cyclin-dependent cdc2 and cdk2 kinase activities in vitro.

Pan ZQ, Hurwitz J.

J Biol Chem. 1993 Sep 25;268(27):20433-42.

17.

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.

Jämsä A, Hasslund K, Cowburn RF, Bäckström A, Vasänge M.

Biochem Biophys Res Commun. 2004 Jul 2;319(3):993-1000.

PMID:
15184080
18.

The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease.

Ding XL, Husseman J, Tomashevski A, Nochlin D, Jin LW, Vincent I.

Am J Pathol. 2000 Dec;157(6):1983-90.

20.

Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease.

Husseman JW, Hallows JL, Bregman DB, Leverenz JB, Nochlin D, Jin LW, Vincent I.

J Neuropathol Exp Neurol. 2001 Dec;60(12):1219-32.

PMID:
11764094

Supplemental Content

Support Center